UK based CQC registered healthcare provider for genetic testing, backed by NHS England. Having designed their Cardiac genetic test and filed a patent already, the team now seek to expand their testing and telemedicine service into new markets.
Company description
Rightangled is a CQC registered healthcare provider for genetic testing. Our first product “Heart DNA Test” is a cardiac genetic test for hereditary conditions, drug response and genetic predisposition to high cholesterol, triglyceride, and other nutrient levels.
Our service is inclusive of a cardiologist assessment who takes into account the patient’s self-reported medical information. Our online platform has three features:
— Medical consultations via Telemedicine
— Automated interpretation system — we convert genetic raw data into a comprehensive report (algorithms and calculations are based on a year of R&D at Birmingham Research Park and have been reviewed by genetic consultants from Guys and St Thomas Hospital in London).
— Automated assignment of patients to consultants based on an integrated barcode identification system.
Since its launch in June 2017, the business has recorded sales in the UK and the US won the Highly Commended award for its economic impact and was listed within the Innovation 50 report for most forward-thinking companies in the region (Miles and Reeve 2017).
We will be launching our next product “Fitness DNA Test” in Q2 2018; more focused on exercise responses, diet and nutrition and cardio fitness in general. R&D for this test has already been completed.
Further DNA tests in our pipeline are for cancer, skincare and mental health medication.
Products: Genetics, testing, cardiac, fitness, digital, platform, telemedicine, medical, consultation, healthcare.
